Almac, which operates 18 facilities including Europe, the USA and Asia, is at the forefront of developing, manufacturing, testing and distributing essential medicines to patients around the world.

Almac Discovery and Immune Therapy Holdings (ITH), a spin out company from the Karolinska Institute, Stockholm, today announced that they have engaged in a collaboration to develop a novel medical ...

Almac Discovery and the Royal College of Surgeons in Ireland (RCSI) have teamed up to research the effect of ALM201 on cancer stem cells. Early preclinical data suggest ALM201 may render cancer ...